Two brothers in Acre, Brazil, face rare genetic disorder with adapted routines and hope for treatment
Pedro Rodrigues, 12, and his younger brother Tiago Rodrigues, 7, residents of Rio Branco, Acre, are living with Limb-Girdle Muscular Dystrophy type 2C (LGMD2C), an ultra-rare genetic condition causing progressive muscle weakness. This has necessitated significant adaptations to their daily lives, limiting physical activities like running and strenuous play. Their mother, lawyer Fabíula Albuquerque Fleming, notes that while Pedro can no longer perform simple actions like getting up from the floor without assistance, Tiago, though younger, is beginning to show similar signs of muscle weakness. The brothers previously led active childhoods but have gradually lost strength over the years.
Their treatment involves specialized physiotherapy three times a week in Rio Branco, following protocols from doctors in São Paulo, and respiratory function monitoring. Their school has also adapted their routines, with special attention from teachers to ensure safety during breaks and to support their learning. While Tiago can still engage in many activities, his mother observes a noticeable decrease in his speed and strength compared to peers. In advanced stages, LGMD2C can affect respiratory and cardiac muscles.
Recently, the family found renewed hope with a clinical trial for LGMD2C in the United States. Four children in the initial phase showed significant improvements, including reduced muscle inflammation and increased strength. Pedro and Tiago have been selected for the second phase, but participation requires approximately $1 million USD (R$ 5.2 million) for treatment, excluding travel and living expenses. Pedro must receive the therapy before his 13th birthday. To fund this, the family is conducting an online fundraising campaign, which has raised R$ 157,240.88 so far, and organized a public awareness event.
This report details the profound impact of a rare genetic disorder on two young brothers, highlighting the challenges of progressive muscle weakness and the family's proactive adaptation and pursuit of advanced medical treatments. The narrative underscores the critical role of specialized healthcare, including physiotherapy and expert consultation across different states, in managing chronic conditions. Furthermore, it illustrates the growing reliance on international clinical trials and the significant financial and logistical hurdles families face in accessing potentially life-changing experimental therapies. The story also brings to light the increasing efficacy of genetic research and the development of targeted treatments for previously untreatable conditions, offering a beacon of hope for rare disease communities globally. The family's fundraising efforts demonstrate a powerful grassroots mobilization in the face of immense medical and financial challenges, reflecting a broader trend in patient advocacy and the search for innovative solutions.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.